Labiotech.eu

News and Trends 26 May 2020

Argenx’s Rare Disease Treatment Strikes Gold in Phase III

The Dutch biotech argenx aims to apply for FDA approval of its lead candidate efgartigimod after the first-in-class drug improved motor symptoms of the autoimmune disease myasthenia gravis in a phase III trial. The phase III trial tested the effect of efgartigimod in 167 patients with generalized myasthenia gravis. In this incurable chronic condition, the […]

May 26, 2020 - 3 minutesmins - By Jonathan Smith

In Depth 25 May 2020

Could Cell Therapy Target the Symptoms of Severe Covid-19?

The excessive inflammatory response seen in the most serious cases of Covid-19, along with shortages of ventilators, has caused a healthcare crisis in many countries around the world. Could cell therapy provide an answer to this dilemma? Most people who become infected with Covid-19 experience symptoms such as a dry cough and mild fever, and […]

May 25, 2020 - 5 minutesmins - By Helen Albert

News and Trends 25 May 2020

Evonik and Beiersdorf Team Up to Turn CO₂ into Skin Care Products

The German companies Evonik and Beiersdorf will work together on a joint research project to investigate how bacteria can be used to turn carbon dioxide (CO₂) and water into raw materials for skincare products. The process will be built on Evonik’s artificial photosynthesis technology – being developed independently of this project in collaboration with Siemens […]

May 25, 2020 - 2 minutesmins - By Laura Cowen

balmes transplantation kidney disorders 1

News and Trends 22 May 2020

Phase II Fail Ends Swiss-US Drug for Rare Kidney Disease

An initially promising drug has failed to show benefits in a phase II trial for the rare kidney disease focal segmental glomerulosclerosis (FSGS), prompting the US biotech ChemoCentryx and its Swiss collaborator Vifor Pharma to drop it for this indication. Topline results from the phase II trial showed that 12 weeks of treatment with the […]

May 22, 2020 - 2 minutesmins - By Anita Chakraverty

Interview 21 May 2020

What 2019 Can Teach About European Biotech Investments Going Forward

Following 2018’s bumper harvest for equity funding in European biotech, 2019 proved even more lucrative, particularly for private biotech companies. What are the biggest investment lessons learned from 2019, and how could Covid-19 change the dynamic in 2020? With the coronavirus pandemic thrusting global industry sectors into chaos, investors and entrepreneurs need to understand the […]

May 21, 2020 - 9 minutesmins - By Jonathan Smith

News and Trends 20 May 2020

Phase II Success for Once-a-Day Eye Drops after Cataract Surgery

A nanoparticle steroid therapy developed by Swiss biotech Oculis has reduced eye pain and inflammation in a phase II trial in cataract surgery patients. This is the second positive phase II this year for the company, which closed a €31M Series B fundraising round at the beginning of 2019. In February this year, Oculis also […]

May 20, 2020 - 3 minutesmins - By Helen Albert

News and Trends 20 May 2020

Antibacterial Eliminates Recurrence of C. Difficile Infections in Phase II

MGB Biopharma has reported positive results from a phase II trial showing that its antibacterial treatment for Clostridium difficile infections cured 100% of the patients, who showed no recurrence four weeks after. The bacterium Clostridium difficile causes life-threatening infections in the intestine and is the most common cause of diarrhea. Current treatments against it […]

May 20, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

novartis spinal muscular atrophy gene therapy

News and Trends 19 May 2020

Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU

Update (19/05/2020): The gene therapy Zolgensma, developed by the big pharma Novartis and approved in the US last year, has received conditional approval in Europe for the treatment of spinal muscular atrophy (SMA). The gene therapy is approved to treat patients with a clinical diagnosis of SMA type 1 or SMA patients that have up […]

May 19, 2020 - 5 minutesmins - By Jonathan Smith

In Depth 18 May 2020

Will Covid-19 Change the Face of Vaccine Development?

The unprecedented scale of the current Covid-19 pandemic has led to a vaccine ‘race’ the like of which has never been seen before. This may change the face of vaccine development forever. Since the English physician Edward Jenner invented the first smallpox vaccine in 1796, vaccines have resulted in dramatic reductions in deaths from previously […]

May 18, 2020 - 13 minutesmins - By Helen Albert

News and Trends 18 May 2020

Update: Spanish Food Startup Raises €12M to Grow Healthier Animal Fats

Update (18/05/2020): Cubiq Foods has received a €5M investment from food technology investor Blue Horizon Ventures. With the funds, the startup aims to accelerate the production of its omega 3 fat additives based on cell culture, expecting to launch two products by the end of the year. 31/01/2019 Based in Barcelona, Cubiq Foods is developing […]

May 18, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 May 2020

Affibody Signs €208M Deal To Market Autoimmune Drug in China

Swedish biotech Affibody and Chinese firm Inmagene Biopharmaceuticals will work together to develop and commercialize Affibody’s phase II-stage drug for autoimmune diseases such as psoriasis. Under the agreement, Inmagene will commercialize Affibody’s treatment in the Greater China region and South Korea, as well as develop the drug in the Asia Pacific region excluding Japan. Meanwhile, […]

May 15, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 15 May 2020

Synthetic Biology Could Lead to Clean Energy Using Light and Carbon Dioxide

Researchers in Germany and France have combined synthetic biology with microfluidics to create artificial photosynthetic droplets, which could lead to the production of organic chemicals and clean fuels that is more efficient than nature can achieve alone. In a study recently published in Science, the research team developed an automated way to produce artificial versions […]

May 15, 2020 - 3 minutesmins - By David Kirk

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Argenx’s Rare Disease Treatment Strikes Gold in Phase III

Could Cell Therapy Target the Symptoms of Severe Covid-19?

Evonik and Beiersdorf Team Up to Turn CO₂ into Skin Care Products

Phase II Fail Ends Swiss-US Drug for Rare Kidney Disease

What 2019 Can Teach About European Biotech Investments Going Forward

Phase II Success for Once-a-Day Eye Drops after Cataract Surgery

Antibacterial Eliminates Recurrence of C. Difficile Infections in Phase II

Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU

Will Covid-19 Change the Face of Vaccine Development?

Update: Spanish Food Startup Raises €12M to Grow Healthier Animal Fats

Affibody Signs €208M Deal To Market Autoimmune Drug in China

Synthetic Biology Could Lead to Clean Energy Using Light and Carbon Dioxide

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!